Stay updated with breaking news from Matt Roache. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON - Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, today reported its fourth quarter and full year 2023 results and recent business performance. 'In 2023, we made important...
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript February 15, 2024 Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.01 EPS, expectations were $0.2. IRWD isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]
Operator: Thank you for standing by. My name is Aaron, and I will be your conference operator for today.
BOSTON & BASEL, Switzerland--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (“Ironwood”) (Nasdaq: IRWD), a GI-focused healthcare company, and VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointes...
Operator: Good day, and welcome to the Ironwood Pharmaceuticals Q1 2023 Investor Update Conference Call. Today's call is being recorded [Operator Instructions].